PHOENIX, Oct 11, 2005 /PRNewswire-FirstCall via COMTEX/ -- Vital Living (OTC Bulletin Board: VTLV) today announced that effective immediately, Gregg A. Linn has been appointed to serve as the Chief Operating Officer of Vital Living. Mr. Linn will also continue to serve as the Company's Chief Financial Officer, an office that he has held since September 2004.
Vital Living CEO Stuart A. Benson stated, "Gregg is an invaluable member of the Vital Living team. His commitment to our Company and in-depth knowledge of our business and customer base make him the ideal candidate to take an increased leadership role in managing the Company's operations as we continue to grow. Gregg has been instrumental in determining our strategic direction, and I am confident that he will continue to be a driving force in the future success of our business in his expanded role."
Prior to joining Vital Living, Mr. Linn served as the President of Red Rock Management, LLC, a private consulting firm located in Scottsdale, Arizona. From September 1994 to June 2001, Mr. Linn served as Chief Financial Officer of DNA Model Management, LLC, a private fashion/entertainment company located in New York, New York. From October 1993 to August 1994, Mr. Linn served as Chief Financial Officer of Skyline Multimedia Entertainment, Inc., a Nasdaq SmallCap-listed company headquartered in New York City.
About Vital Living, Inc.
Headquartered in Phoenix, Vital Living develops nutritional and nutraceutical products which are marketed for distribution through physicians and licensed or certified healthcare professionals. Vital Living develops and tests its products in collaboration with leading medical experts in the nutritional and nutraceutical fields and have designed them to be incorporated by healthcare practitioners into integrative medical, wellness, and complementary medical protocols.
Vital Living is developing unique, safe and naturally derived nutritional products, utilizing advanced nutraceutical and drug-delivery technologies, including the Geomatrix(TM) technology through its affiliation with SkyePharma PLC. The Geomatrix(TM) technology has been provided exclusively for Vital Living's pharmaceutical development in China, and the development of nutraceuticals on a global basis. For more information on the company, please visit www.vitalliving.com.
Except for any historical information, the matters discussed in this press release contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934.ng s. Forward-looking statements involve risks and uncertainties, including activities, events or developments that the company expects, believes or anticipates will or may occur in the future. A number of factors could cause actual results to differ from those indicated in the forward- looking statements, including the ultimate success of the Company's strategic direction and its business initiatives. Such statements are subject to a number of assumptions, risks and uncertainties. Readers are cautioned that such statements are not guarantees of future performance and those actual results or developments may differ materially from those set forth in the forward-looking statements. The company undertakes no obligation to publicly update or revise forward-looking statements, whether as a result of new information or otherwise.